State maintains zero deaths from lumpy skin disease: Data
Panaji: Goa’s cattle recorded zero cases of lumpy skin disease in 2024-25. This marks yet another year of no deaths due to ...
How your skin may be hurting your health — from worsening dementia risk to aging your heart
“Our skin, by far, is exposed to the most amount of oxidative stress,” he added. That can lead to a host of issues, from skin ...
Physician's Weekly11d
Suicide Risk Among Individuals With Skin Diseases
The following is a summary of “Completed suicide in patients with skin disease: A systematic review and meta-analysis,” ...
Healio6d
Addressing skin disease with medications alone is ‘not enough,’ diet also brings benefits
Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...
Physician's Weekly3d
Skin Involvement and Manifestations in Fabry Disease
The following is a summary of “Cutaneous manifestations of Fabry disease: A systematic review,” published in the March 2025 ...
Check Your Health- Dermatologist's Recommendations for Skin Conditions in a Dry Climate
With the cold and dry weather, Intermountain Health dermatologists say there are easy ways to avoid issues and keep your skin ...
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...
Incyte Leads S&P 500 Decliners on Skin Condition Drug Trial Results
Shares of Incyte sank Monday, making it the biggest decliner in the S&P 500 after the release of its latest clinical trial.
Incyte's skin disease drug fails to impress in late-stage studies; shares drop
Incyte said on Monday its experimental drug has met the main goal in two separate late-stage studies testing it in patients with an inflammatory skin condition called hidradenitis suppurativa.